Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 214 entries
View as:

Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE)

Phase: N/A Priority: Normal
NCT ID: NCT02151539 Org: User:
Start: 08/29/14 End: 10/11/18 Due: 10/11/19

A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade Glioma

Phase: N/A Priority: Normal
NCT ID: NCT01891747 Org: User:
Start: 07/31/13 End: 01/31/22 Due: 01/31/23

Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan

Phase: N/A Priority: Normal
NCT ID: NCT00602147 Org: User:
Start: 07/31/07 End: 04/30/10 Due: 04/30/11

Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00898742 Org: User:
Start: 04/30/07 End: 06/30/10 Due: 06/30/11

Investigation of Pain and Symptom Burden in Patients With Newly Diagnosed Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00655005 Org: User:
Start: 05/31/07 End: 05/31/08 Due: 05/31/09

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00897793 Org: User:
Start: 01/31/06 End: 07/31/10 Due: 07/31/11

Quantitative MRI in Assessing Disease in Patients With Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02269111 Org: User:
Start: 04/30/15 End: 05/31/18 Due: 05/31/19

PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE

Phase: N/A Priority: Normal
NCT ID: NCT00499681 Org: User:
Start: 07/31/07 End: 12/31/10 Due: 12/31/11

Biomarkers in Predicting Response in Patients With Graft-Versus-Host Disease Undergoing Extracorporeal Photophoresis

Phase: N/A Priority: Normal
NCT ID: NCT01324908 Org: User:
Start: 07/31/11 End: 11/16/20 Due: 11/16/21

Skin/Soft Tissue Elasticity in Head and Neck Cancer Survivors With Lymphedema and Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT02676752 Org: User:
Start: 09/30/16 End: 08/31/21 Due: 08/31/22

Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib

Phase: N/A Priority: Normal
NCT ID: NCT01928160 Org: User:
Start: 06/30/14 End: 03/31/15 Due: 03/31/16

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

Phase: N/A Priority: Normal
NCT ID: NCT05361720 Org: User:
Start: 12/01/22 End: 07/01/26 Due: 07/01/27

Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01882231 Org: User:
Start: 03/31/13 End: 04/25/16 Due: 04/25/17

Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00983268 Org: User:
Start: 10/31/09 End: 02/28/13 Due: 02/28/14

Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System

Phase: N/A Priority: Normal
NCT ID: NCT04327999 Org: User:
Start: 10/05/20 End: 09/25/23 Due: 09/25/24

Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT04454476 Org: User:
Start: 11/09/22 End: 12/31/25 Due: 12/31/26

Chemoprevention of Gastric Carcinogenesis

Phase: N/A Priority: Normal
NCT ID: NCT02794428 Org: User:
Start: 09/19/16 End: 07/01/24 Due: 07/01/25

Pain Management Smartphone Application for Patients With Stage III-IV Head and Neck Cancer Undergoing Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02324881 Org: User:
Start: 12/31/14 End: 10/31/15 Due: 10/31/16

FDG-PET in Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02236546 Org: User:
Start: 05/31/12 End: 11/30/15 Due: 11/30/16

Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00651976 Org: User:
Start: 03/31/08 End: 09/30/18 Due: 09/30/19

Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03263429 Org: User:
Start: 08/23/17 End: 12/21/23 Due: 12/21/24

Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT02240381 Org: User:
Start: 11/20/14 End: 01/08/19 Due: 01/08/20

Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study

Phase: N/A Priority: Normal
NCT ID: NCT02685631 Org: User:
Start: 07/31/15 End: 08/31/21 Due: 08/31/22

Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00483457 Org: User:
Start: 02/28/06 End: 11/30/08 Due: 11/30/09

Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00898313 Org: User:
Start: 12/31/03 End: 01/31/25 Due: 01/31/26